Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
European Molecular Biology Laboratory currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 actions are distributed among 4 distinct examiners, meaning each pending matter has a unique reviewer. The portfolio is spread across 3 distinct art units, showing administrative variety within the Biotechnology & Pharmaceuticals field.
TSUI, YUNG-SHENG M is the busiest examiner, holding 1 busiest examiner pending office action. This 1 busiest examiner pending action is consistent with the fact that there are 4 distinct examiners for the 4 pending office actions. No single examiner is handling a disproportionate share of the workload for the laboratory.
The 3 distinct art units manage the 4 pending office actions, suggesting that at least two actions are likely within the same unit. With 4 distinct examiners involved, the laboratory's prosecution strategy is decentralized. TSUI, YUNG-SHENG M is one of the 4 distinct examiners contributing to the current total of 4 pending office actions at European Molecular Biology Laboratory.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TSUI, YUNG-SHENG M | 1 | 66.4% | +6.6% |
| MONTGOMERY, ANN Y | 1 | 69.0% | +27.7% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 36.8% | +72.6% |
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17514269 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 59d overdue |
| 18557184 | HIGH COMPLEXITY MICROCOMPARTMENT-BASED INTERACTION SCREENING | TSUI, YUNG-SHENG M | — |
| 18556778 | QUANTIFICATION OF SUCCESSFUL ENCAPSULATION INTO MICROFLUIDIC COMPARTMENTS | MONTGOMERY, ANN Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17514269 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 59d overdue |
| 18556778 | QUANTIFICATION OF SUCCESSFUL ENCAPSULATION INTO MICROFLUIDIC COMPARTMENTS | MONTGOMERY, ANN Y | — |
| 17782654 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION | SCHACHERMEYER, SAMANTHA LYNN | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| 1693 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18557184 | HIGH COMPLEXITY MICROCOMPARTMENT-BASED INTERACTION SCREENING | TSUI, YUNG-SHENG M | — | §102§112 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18556778 | QUANTIFICATION OF SUCCESSFUL ENCAPSULATION INTO MICROFLUIDIC COMPARTMENTS | MONTGOMERY, ANN Y | 1678 | §102§103§112 | Non-Final OA | — | Pending | Oct 23, 2023 |
| 17782654 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Final Rejection | — | Pending | Jun 05, 2022 |
| 17514269 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 1687 | §101 | Final Rejection | 59d overdue | Pending | Oct 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial